Plant-based high-protein diet compared with usual advice in people with liver cirrhosis
Compares a plant-based high-protein diet with usual diet advice in adults with cirrhosis.
Key facts
- Who runs it
- Agricultural University of Athens
- Where
- Greece2 sites in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- Evaluation of a High Protein Plant Dominant Diet (HiProPlaDo) in Liver Cirrhosis
- Status
- Recruiting
- People taking part
- 100 people, planned
- Started
- 15 Jun 2022
- Planned end
- 29 Dec 2025
- Type of study
- Interventional, 3 groups
- Treatments tested
- Diet based on animal proteins
- Diet based on plant proteins.
- General instructions for patients with liver disease.
- Record updated
- 19 June 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with advanced liver cirrhosis who are waiting for a kidney transplant. It compares a high-protein diet based on plant foods with a diet based on animal protein.
- Age
- 18 Years to 80 Years
- Sex
- All sexes can join.
- Disease stage
- Decompensated cirrhosis: liver scarring that is causing problems, such as fluid in the belly. People must be waiting for a kidney transplant.
- Earlier treatment
- People must not have had dietary advice before.
Main reasons for not taking part
- A mental health illness
- Following a vegetarian diet before joining the trial
- Hepatonephrotic syndrome (liver and kidney problems together) that needs a limit on protein
The registry criteria, word for word
Show all 4 criteriaShow less
Who can take part
- Adult patients with decompensated cirrhosis awaiting kidney transplantation who have not previously received dietary advice
Who cannot take part
- Adoption of a vegetarian diet prior to study entry
- Psychopathological illness
- Hepatonephrotic syndrome requiring protein restriction
The main criteria, as questions
These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Are you between 18 and 80 years old?
This trial is currently available in Greece.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The aim of the study is to compare the implementation of a high-protein diet based on plant-based foods (Group A) with the usual guidelines for liver patients, in which protein needs are met by low-fat animal foods (Group B). The parameters that will be studied concern:
Read full original descriptionShow less
1. Liver function 2. Nutritional status and the risk of malnutrition 3. Body composition, with emphasis on muscle mass
3. Muscular system functionality and sarcopenia 4. The intestinal microbiome 5. The quality of life of the patients
This is a randomized, double-blind intervention study lasting 6 months, during which volunteers will be asked to answer, with the help of the researchers, questionnaires assessing nutritional risk, assessing physical activity and quality of life, and assessing nutritional intake (24-hour food recall and Food Frequency Questionnaire). At the same time, a blood sample will be collected for analysis of inflammatory factors and indicators related to nutritional status (albumin, prealbumin, cholesterol, total iron binding capacity). Body composition will be assessed using the method of anthropometry and dual-energy X-ray absorptiometry (DEXA), and hand dynamometry to assess functionality. The assessment of the microbiome will be performed by saliva collection and/or stool collection. The impact on liver function will be assessed by recording every 3 months a) natriuresis/microalbuminuria (in 24-hour urine collection or urine sample) and the severity of ascites (grade I, II, III), b)ammonia levels and episodes of encephalopathy, c) complications of cirrhosis, such as variceal hemorrhage, encephalopathy, spontaneous bacterial peritonitis and renal dysfunction, d) liver disease severity assessment scores, such as MELD and Child-Pugh scores.
The aim of the study is to see if there is a difference in sarcopenia and the values of various biochemical indicators between patients who received plant-based proteins compared to patients who received animal-based proteins.
The 3 groups in the trial
- Group A (diet with animal protein).Treatment being tested
In group Α, a diet was designed based on the needs of each individual, based on proteins of animal origin.
Treatment: Diet based on animal proteins
- Group B (diet with plant based protein).Treatment being tested
In group B, a diet was designed based on the needs of each individual, based on proteins of plant origin.
Treatment: Diet based on plant proteins.
- Group C (control)Other group
Control group who were given general instructions for patients with liver disease.
Treatment: General instructions for patients with liver disease.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Evaluation of a High Protein Plant Dominant Diet (HiProPlaDo) in Sarcopenia, Quality of Life and Metabolic Parameters in Patients With Liver Cirrhosis: A Randomized Clinical Trial
- Plain-language title
- Plant-based high-protein diet compared with usual advice in people with liver cirrhosisGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Criteria questions
- Built from NCT07028580, who can take part
- Record updated
- 19 June 2025